Negenborn et al. (2016) conducted a systematic review of MEDLINE, Cochrane Library, EMBASE, and Web of Science, including 26 clinical studies involving 905 patients who underwent autologous fat grafting for application in scar tissue.
Key finding: ALL 26 studies reported a beneficial effect on scar tissue. Five studies documented statistically significant improvements in appearance, skin characteristics, and pain.
IMPORTANT LIMITATION: the level of evidence was predominantly low to intermediate (level III/IV on the Oxford OCEBM scale). Randomized controlled trials with greater methodological rigor are still needed.
| Type | PRISMA systematic review. Databases: MEDLINE, Cochrane, EMBASE, Web of Science. No language restrictions. |
| Period | Studies published between January 2004 and August 2014. |
| Inclusion | RCTs, prospective and retrospective cohorts, case-control studies. Criteria: ≥5 patients, follow-up ≥6 months. |
| Screening results | 17,956 articles screened by title → 26 studies included, 905 patients. |
| Levels of evidence | Level II: 5 studies (4 RCTs). Level III: 7 studies. Level IV: 14 studies. |
| Statistical analysis | Meta-analysis NOT performed — methodological heterogeneity. Narrative synthesis. |
Adding stromal vascular fraction (SVF) to the autologous fat graft increased volume retention from 39% to 63% in a prospective comparative study (Gentile et al. 2014). This directly supports the argument for the quality of cryopreserved material — the presence of ASCs in the sample is a determining factor in the outcome. LipAge Score Domain 3 (SVF preservation) has a direct clinical basis here.
| Postmastectomy pain syndrome | Caviggioli et al. 2011 (RCS, n=113): statistically significant pain reduction (VAS: 3.23 vs. 1.04). Maione et al. 2014 (n=88): confirmation of the effect. LEVEL OF EVIDENCE: II and III. |
| Painful and contractile scars | Klinger et al. 2013 (n=20): significant pain reduction on the POSAS scale after 12 months. Proposed mechanism: changes in the microenvironment through secretions from mesenchymal cells in the graft. |
| Vaginal/perineal scars after episiotomy | Ulrich et al. 2012 (n=20): significant reduction on the McGill Pain Questionnaire and VAS after 6 months. |
| Painful surgical scars | Baptista et al. 2013 (n=11): complete disappearance of pain in 27% of patients; reduced analgesic use in 72.7%. |
Results varied — the mechanism of action on pruritus remains poorly understood. The evidence is insufficient for a definitive conclusion on this specific outcome.
1. Predominantly low level of evidence: 14 of the 26 studies are level IV. Only 4 RCTs were included.
2. Small samples: most studies had n<50 patients. Meta-analysis was not possible because of heterogeneity.
3. Positive publication bias: the authors explicitly caution that all 26 studies reported positive results — which is not epidemiologically plausible without bias.
4. Short follow-up: 6 to 21 months in most studies. Long-term data (>2 years) are scarce.
5. Technical heterogeneity: AFG techniques varied (Coleman vs. non-Coleman), as did volumes — making it impossible to isolate the specific effect of AFG.
| Title | The Use of Autologous Fat Grafting for Treatment of Scar Tissue and Scar-Related Conditions: A Systematic Review |
| Authors | Negenborn VL, Groen J-W, Smit JM, Niessen FB, Mullender MG |
| Journal | Plastic and Reconstructive Surgery — American Society of Plastic Surgeons |
| Year | 2016 — DOI: 10.1097/PRS.0000000000001850 |
| N | 26 clinical studies · 905 patients |
| Relevance to LipAge | High — supports scars as a robust indication and demonstrates the role of SVF in volume retention |